Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|March 13, 2015
Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancerGayathri Nagaraj, Cynthia Ma
Breast Cancer Research and Treatment|November 21, 2007
Femara and the future: tailoring treatment and combination therapies with FemaraMatthew Ellis, Cynthia Ma
Breast Cancer Research and Treatment|November 21, 2007
Letrozole in the neoadjuvant setting: the P024 trialMatthew J Ellis, Cynthia Ma
Surgical Oncology Clinics of North America|November 15, 2017
Neoadjuvant Endocrine Therapy: Who Benefits Most?Julie Grossman, Cynthia Ma, Rebecca Aft
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Improving Response to Hormone Therapy in Breast Cancer: New Targets, New Therapeutic OptionsHope S Rugo, Neelima Vidula, Cynthia Ma
Annals of Surgical Oncology|March 19, 2015
Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution ExperienceThanh U Barbie, Cynthia Ma, Julie A Margenthaler
International Journal of Breast Cancer|February 2, 2012
Molecular basis of triple negative breast cancer and implications for therapyParvin F Peddi, Matthew J Ellis, Cynthia Ma
The Journal of Clinical Ethics|March 18, 2022
COVID-19 Ethics Debrief: Pearls and Pitfalls of a Hub and Spoke ModelCynthia Ma Geppert, Kenneth A Berkowitz, Toby Schonfeld, et al.
Nature Reviews. Clinical Oncology|February 29, 2012
Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancerRodrigo Goncalves, Cynthia Ma, Jingqin Luo, et al.
Mayo Clinic Proceedings|January 26, 2005
Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndromeKeith W Pratz, Cynthia Ma, Marie-Christine Aubry, et al.
Pageof 7